Wnt1 |
Canonical |
SCC1483, SNU1076 |
Oral squamous cell carcinoma |
Promote invasion, inhibit apoptosis |
Rhee et al., 2002; Zhang C. et al., 2019
|
Wnt3 |
Canonical |
– |
Oral leukoplakia |
Cause dysplasia |
Ishida et al., 2007 |
Wnt3a |
Canonical |
– |
Laryngeal squamous cell carcinoma |
Worse histological grade, advanced clinical stage, and higher cervical lymph node metastatic potential |
Zhang D. et al., 2019 |
Wnt4 |
Non-canonical |
WRO, CAL62, FB2, and BCPAP |
Thyroid carcinoma |
Reduce migration |
Filippone et al., 2014 |
Wnt5a |
Non-canonical |
SCC9 |
Oral squamous cell carcinoma |
Enhance migration and invasion |
Prgomet et al., 2017 |
Wnt5a |
Non-canonical |
HTH-74, C-643 |
Thyroid carcinoma |
Decrease proliferation, migration, invasiveness, and clonogenicity |
Kremenevskaja et al., 2005 |
Wnt5a |
Non-canonical |
CNE-2, 5-8F |
Nasopharyngeal carcinoma |
Lead to tumorigenesis and metastasis |
Zhu et al., 2014; Qin et al., 2015
|
Wnt5a |
Non-canonical |
– |
Laryngeal squamous cell carcinoma |
High tumor stage and lymph node metastasis |
Prgomet et al., 2017 |
Wnt5b |
Non-canonical |
SAS-LM8 |
Oral squamous cell carcinoma |
Enhance migration and invasion |
Zhang et al., 2017 |
Wnt7a |
Canonical |
HSC3, CAL27 |
Oral squamous cell carcinoma |
Promote migration |
Sakamoto et al., 2017 |
Wnt7b |
Canonical |
DOK, FaDu |
Oral squamous cell carcinoma |
Promote proliferation and invasion |
Xie et al., 2020 |
Wnt10b |
Canonical |
SNU1076 |
Head and neck squamous cell carcinoma |
Promote growth and survival, inhibit apoptosis |
Shiah et al., 2014 |
Wnt11 |
Non-canonical |
– |
Oral squamous cell carcinoma |
Suppress tumor |
Andrade Filho et al., 2011 |